PNPLA8 anticorps (Middle Region)
-
- Antigène Voir toutes PNPLA8 Anticorps
- PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat, Lapin, Cheval, Boeuf (Vache), Chien, Cobaye, Poisson zèbre (Danio rerio)
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PNPLA8 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- IDNRTRALVQ ALRRTTDPKL CITRVEELTF HLLEFPEGKG VAVKERIIPY
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 92%
- Attributs du produit
- This is a rabbit polyclonal antibody against PNPLA8. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human PNPLA8
- Top Product
- Discover our top product PNPLA8 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 782 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes." dans: PLoS ONE, Vol. 8, Issue 8, pp. e71748, (2013) (PubMed).
: "
-
Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes." dans: PLoS ONE, Vol. 8, Issue 8, pp. e71748, (2013) (PubMed).
-
- Antigène
- PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))
- Autre désignation
- PNPLA8 (PNPLA8 Produits)
- Synonymes
- anticorps IPLA2(GAMMA), anticorps IPLA2-2, anticorps IPLA2G, anticorps iPLA2gamma, anticorps 1200006O19Rik, anticorps AI467579, anticorps Ipla2(gamma), anticorps RGD1311444, anticorps iPLA2, anticorps patatin like phospholipase domain containing 8, anticorps patatin-like phospholipase domain containing 8, anticorps PNPLA8, anticorps Pnpla8
- Sujet
-
Phospholipase A2 catalyzes cleavage of fatty acids from phospholipids, thereby regulating membrane physical properties and the release of lipid second messengers and growth factors. Phospholipase A2 activity also modulates cellular growth programs, inflam
Alias Symbols: IPLA2(GAMMA), IPLA2-2, IPLA2G
Protein Interaction Partner: UBC,
Protein Size: 782 - Poids moléculaire
- 88 kDa
- ID gène
- 50640
- NCBI Accession
- NM_015599, NP_056538
- UniProt
- Q9NP80
-